Skip to content

Our health facilities are still unsafe: why we all need to do something about TB infection control

Low rate of toxicity-related treatment change suggests HIV treatment tolerable in the long-term

Survival after cryptococcal meningitis not improving despite ART in Uganda

Does tenofovir increase the risk of efavirenz-associated liver side-effects?

BHIVA: Many patients and clinicians still need educating about the benefits of treatment

African-Americans with HIV have higher risk of aggressive kidney disease

Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals

Daily micronutrients of some benefit for HIV-positive patients receiving TB treatment

Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy